Table 1. Characteristics of normal and metastatic cancer samples analyzed for peripheral templates.
| Characteristic | Number | Range (%) | |
|---|---|---|---|
| Normal Controls | |||
| Number | |||
| total Normals | 31 | ||
| Age (years) | |||
| Median | 48 | 30-74 | |
| Sex | |||
| Male | 13 | (42%) | |
| Female | 15 | (48%) | |
| Unknown | 3 | (10%) | |
| Metastatic Cancer Samples | |||
| Number | |||
| Total | 32 | ||
| Age (years) | |||
| Median | 55 | 36-82 | |
| Sex | |||
| Male | 1 | (3%) | |
| Female | 31 | (97%) | |
| BC subtype | |||
| Luminal A | 15 | (47%) | |
| Luminal B | 6 | (19%) | |
| Her2 | 4 | (13%) | |
| TNBC | 6 | (19%) | |
| Unknown | 1 | (3%) | |
| Pathologic stage | |||
| Stage IV | 31 | (97%) | |
| Unknown | 1 | (3%) | |
| No. of lines of Therapy | |||
| Median | 4 | 0-13 | |
| Sampling Interval | |||
| Synchronous (≤6 months) | 17 | 0-18 weeks (53%) | |
| Asynchronous (≥6 months) | 14 | 31-240 weeks (44%) | |
| Not available | 3 | (3%) | |